An effective system for senescence modulating drug development using quantitative high-content analysis and high-throughput screening.
Abstract
Study of cellular senescence is critical in aging research and anti-senescence therapy drug development. Current methods for the evaluation of the widely accepted cellular senescence marker senescence-associated beta galactosidase (SA-β-gal) activity assay rely on bright-field imaging, which is non-quantitative and tedious to perform. We have developed an effective and reproducible multiplex high-content analysis system for high-throughput screen and evaluation of senescence modulators. The IC
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims to have developed a multiplex high-content analysis system for high-throughput screening of senescence modulators. This research is relevant as it addresses cellular senescence, a key factor in aging and age-related diseases, and proposes a novel method for evaluating potential anti-senescence therapies.
Author of this paper? Send a correction.